LI85008F
Commercial- Indications
- Obesity, Type 2 diabetes
Company intelligence / Profile preview
Laila Nutraceuticals develops and manufactures herbal extracts and dietary supplements. The company has filed patents for novel blends such as a combination of Bacopa monnieri and Terminalia chebula for brain health, targeting cognitive decline through acetylcholinesterase inhibition. Their products are available in various forms including capsules, powders, gummies, and functional foods. Clinical results are not publicly detailed but the company claims synergistic efficacy in preclinical or early-stage studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laila Nutraceuticals.